Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000308930 | SCV000337085 | uncertain significance | not provided | 2015-11-02 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001085652 | SCV000625960 | likely benign | Duchenne muscular dystrophy | 2024-01-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000620173 | SCV000736904 | likely benign | Cardiovascular phenotype | 2021-06-24 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000308930 | SCV000984234 | benign | not provided | 2020-10-16 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 19937601) |
Revvity Omics, |
RCV000308930 | SCV003834733 | uncertain significance | not provided | 2021-04-12 | criteria provided, single submitter | clinical testing |